• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Management Inquiry >A Bitter Pill? Institutional Corruption and the Challenge of Antibribery Compliance in the Pharmaceutical Sector
【24h】

A Bitter Pill? Institutional Corruption and the Challenge of Antibribery Compliance in the Pharmaceutical Sector

机译：苦药？机构腐败和制药行业反贿赂合规的挑战

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

We investigate why top-down directives aimed at eradicating corruption are ineffective at altering on-the-ground practices for organizations that have adopted industry-wide gold standards to prevent bribery and corruption. Using interview and focus group data collected from leading multinational pharmaceutical firms, we unearth antecedents contributing to organizations' systemic failure to embed their anticorruption policies in business practice. We identify two tensions that contribute to this disconnect: a culture clash between global and local norms, especially in emerging markets and a similar disconnect between the compliance and commercial functions. To overcome these tensions, we suggest that organizations are likely to find it easier to implement a no gifts policy if they cease to rely on local agents embedded in local norms and that there needs to be strong evidence of board-level commitment to antibribery programs, innovative ways of incentivizing compliant behavior, and a fundamental rethinking of organizations' business model and remuneration practices.
机译：我们调查了为什么旨在消除腐败的自上而下的指令对于改变采用行业范围内的金本位制以防止贿赂和腐败的组织的实地做法无效，从而导致无效。利用从领先的跨国制药公司收集的访谈和焦点小组数据，我们发现了导致组织系统性失败的前因，无法将其反腐败政策嵌入到商业实践中。我们发现造成这种脱节的两种紧张关系：全球规范与地方规范之间的文化冲突，尤其是在新兴市场，以及合规与商业职能之间的类似脱节。为克服这些紧张关系，我们建议组织如果不再依赖嵌入本地规范中的本地代理商，可能会更容易实施不赠与政策，并且需要有强有力的证据表明董事会对反贿赂计划的承诺，激励合规行为的创新方法，并对组织的业务模式和薪酬惯例进行根本性的重新思考。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号